Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effectiveness of Yong Chong Cao capsule on outcomes
in patients with mild to severe Chronic Obstructive Pulmonary Disease (COPD).
Phase:
Phase 3
Details
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Collaborator:
Jiangsu Famous Medical Technology Co., Ltd.
Treatments:
Albuterol Bromides Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Tiotropium Bromide Xhance